Витавис в качестве средства сопровождения комбинированного лечения больных раком молочной железы
А К Антонов, Aleksandra Filimoniuk, С. В. Стражев et al. · Земский врач · 2012
The results of clinical observations have shown that the use of Vitavis as immunological maintenance compound during breast cancer combination therapy significantly reduces the incidence of chemotherapy toxic manifestations and has an immune corrective effect.
Cited by 0 works.